Isaac Ro

Director/Board Member at SEER, INC.

Net worth: 76 670 $ as of 2026-05-30

48 year

100 connections

Finance

Health Technology

Health Services

Profile

Isaac Ro currently works at Haystack Oncology, Inc., as Executive Chairman, Seer, Inc. (California), as Director from 2025, Bioct Innovation Commons, as Director, and Catalio Capital Management LP, as Partner from 2023.
Mr. Ro also formerly worked at Leerink Partners LLC, as Director from 2004 to 2010, Independence Investments LLC, as Research Associate, Goldman Sachs & Co. LLC, as Analyst from 2013 to 2019, Aberdeen Content LLC, as Research Associate, Thrive Earlier Detection Corp., as Chief Financial Officer from 2019 to 2021, and GeneDx Holdings Corp., as Chief Financial Officer from 2021 to 2022.
Mr. Ro received his undergraduate degree in 2000 from Middlebury College.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
SEER, INC. CLASS A 0.07%	2025-09-01	41,000 ( 0.07% )	76 670 $	2026-05-30

Isaac Ro active positions

Companies	Position	Start
SEER, INC.	Director/Board Member	2025-09-01
Bioct Innovation Commons	Director/Board Member	-
Haystack Oncology, Inc. Haystack Oncology, Inc. Medical/Nursing ServicesHealth Services Operates as an oncology care and MRD testing center	Chairman	-
Catalio Capital Management LP Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments.	Private Equity Investor	2023-03-31

All active positions of Isaac Ro

Former positions of Isaac Ro

Companies	Position	End
GENEDX HOLDINGS CORP.	Director of Finance/CFO	2022-06-09
Thrive Earlier Detection Corp. Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Develops liquid biopsy test that is designed to detect cancers at early stages	Director of Finance/CFO	2021-01-31
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	2019-05-31
Leerink Partners LLC Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services	Analyst-Equity	2010-05-30
Independence Investments LLC Independence Investments LLC Investment ManagersFinance Independence follows a multi-dimensional investment process applying fundamental research and quantitative modeling to create return predictions. In fundamental research, analysts determine how economic and competitive forces are likely to shape the prospects for each of the companies in their investment universe. The analysts interview the management of these companies, as well as suppliers, customers, competitors and other industry experts. Quantitative research is then used to translate these fundamental insights into computer-based methods for stock selection. Independence's investment philosophy and process seeks to minimize style and sector biases.	Corporate Officer/Principal	-

See the detail of Isaac Ro's experience

Training of Isaac Ro

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Isaac Ro's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Independence Investments LLC Independence Investments LLC Investment ManagersFinance Independence follows a multi-dimensional investment process applying fundamental research and quantitative modeling to create return predictions. In fundamental research, analysts determine how economic and competitive forces are likely to shape the prospects for each of the companies in their investment universe. The analysts interview the management of these companies, as well as suppliers, customers, competitors and other industry experts. Quantitative research is then used to translate these fundamental insights into computer-based methods for stock selection. Independence's investment philosophy and process seeks to minimize style and sector biases.	Finance
Goldman Sachs & Co. LLC Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Leerink Partners LLC Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services	Finance
Aberdeen Content LLC Aberdeen Content LLC Miscellaneous Commercial ServicesCommercial Services Provides fact based research services	Commercial Services
Middlebury College Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Seer, Inc. (California) Seer, Inc. (California) BiotechnologyHealth Technology Provides research and development services for biotechnology	Health Technology
Thrive Earlier Detection Corp. Thrive Earlier Detection Corp. Medical SpecialtiesHealth Technology Develops liquid biopsy test that is designed to detect cancers at early stages	Health Technology
Catalio Capital Management LP Catalio Capital Management LP Investment ManagersFinance Catalio Capital invests in public and private companies located in the United States. The firm targets companies operating in the fields of life sciences developing next-generation drugs, devices and diagnostics, data, tools and innovative healthcare sectors. It provides financing for seed, early and later stage capital requirements and also makes co-investments.	Finance
GeneDx Holdings Corp. GeneDx Holdings Corp. Medical/Nursing ServicesHealth Services Provides diagnostic genetic testing services	Health Services
Bioct Innovation Commons	Finance
Haystack Oncology, Inc. Haystack Oncology, Inc. Medical/Nursing ServicesHealth Services Operates as an oncology care and MRD testing center	Health Services